Published Date: 17 Feb 2023
United States: Infrequent sleep, particularly chronic sleep, in adults aged 45 and older is associated with numerous measures of...
Read Full NewsAs part of NeurologyLive®'s Year in Review, take a look at some of the top ongoing clinical trials in Parkinson disease that may impact care.
ALS expert Sabrina Paganoni, MD, PhD, provided follow-up commentary on promising phase 1 data from the LUMINA trial testing Amylyx’s novel agent AMX0114 in patients with early-stage ALS.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on preventative migraine therapies!
Benjamin Greenberg, MD, MHS, a nationally recognized neuroimmunologist, spoke about the clinical impact of the latest NMOSD recommendations and their implications for diagnosis and care.
4 Psychiatry Headlines You Missed in December 2025
6 Nephrology Headlines You Missed in December 2025
Residential Neighborhood Disadvantage May Lower Kidney Transplant Access
1.
Study sets benchmark for treatment of advanced cervical cancer
2.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
3.
Children with rare gliomas have new hope thanks to clinical trial results.
4.
Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement
5.
For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.
1.
CAR T-Cell Therapy: Revolutionizing Hematologic Malignancies
2.
Beyond the Organs: Navigating the Era of Tissue-Agnostic Therapies in Modern Cancer Management
3.
How AI is Transforming Diagnostics, Drug Discovery, and Personalized Oncology
4.
All You Need To Know About Cancer Antigen 27-29: Causes, Symptoms & Treatment
5.
Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
3.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation